2021 COCA Calls/Webinars Information, Summaries, & Slide Sets

Title: Pediatric COVID-19 Vaccines: CDC’s Recommendations for COVID-19 Primary Series in Children 5–11 years old

Date: Thursday, November 4, 2021

Presenters:
To be Announced


Title: What Clinicians Need to Know about the Recent Updates to CDC’s Recommendations for COVID-19 Boosters

Date: Tuesday, October 26, 2021

Presenters:
To be Announced


Title: 2021–2022 Recommendations for Influenza Prevention and Treatment in Children: An Update for Pediatric Practitioners

Date: Thursday, October 7, 2021

Presenters:
David Shay, MD
Medical Officer
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention

Flor Munoz, MD, MSc, FAAP
Associate Professor of Pediatrics, Infectious Diseases, and Molecular Virology and Microbiology
Baylor College of Medicine


Title: Evaluating and Supporting Patients Presenting With Fatigue Following COVID-19

Date: Thursday, September 30, 2021

Presenters:
Maureen Miller, MD, MPH
Research, Surveillance, and Management Unit
Natural History/Post-COVID Conditions Team
Epidemiology Task Force
COVID-19 Response
Centers for Disease Control and Prevention

Joseph E. Herrera, DO
Professor and System Chair of Rehabilitative Medicine
Department of Rehabilitation and Physical Medicine
Mount Sinai Health System

Monica Verduzco Gutierrez, MD
Professor and Chair of Physical Medicine and Rehabilitation
Department of Physical Medicine and Rehabilitation
UT Health San Antonio

Benjamin Abramoff, MD, MS
Assistant Professor of Clinical Physical Medicine and Rehabilitation
Department of Physical Medicine and Rehabilitation
Penn Medicine


Title: What Clinicians Need to Know About the Latest CDC Recommendations for Pfizer-BioNTech COVID-19 Booster Vaccination

Date: Tuesday, September 28, 2021

Presenters:
Dr. Ruth Link-Gelles, PhD, MPH
Co-lead COVID-19 Vaccine Effectiveness Team
Epidemiology Task Force
COVID-19 Response
Centers for Disease Control and Prevention

Dr. Anne Hause, PhD, MSPH
Co-Lead V-safe Team
Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention

Dr. Neela Goswami, MD, MPH
Lead Clinical Guidelines Team
Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention


Title: 2021-2022 Influenza Vaccination Recommendations and Guidance on Coadministration with COVID-19 Vaccines

Date: Thursday, September 09, 2021

Presenters:
CAPT Lisa Grohskopf, MD, MPH
Medical Officer, Influenza ACIP Lead
Epidemiology and Prevention Branch
Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention

Andrew Kroger, MD, MPH
Medical Officer
Communication and Education Branch
Immunization Services Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention


Title: Additional mRNA COVID-19 Vaccines for Moderately to Severely Immunocompromised People

Date:
Tuesday, August 17, 2021

Presenters:
Kathleen Dooling, MD, MPH
ACIP Workgroup Team Lead
Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention

Neela Goswami, MD, MPH
Clinical Guidelines Team Lead
Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention

Tom Shimabukuro, MD, MPH, MBA
CAPT, U.S. Public Health Service
Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention

Katherine Shealy, MPH, IBCLC
Vaccine Clinical Inquiry Management Team Lead
Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention


Title: Therapeutic Options to Prevent Severe COVID-19 in Immunocompromised People

Date:
Thursday, August 12, 2021

Presenters:
Elliot Raizes, MD
Task Force Lead
Health Services and Worker Safety Task Force
COVID-19 Response
Centers for Disease Control and Prevention

John Farley, MD, MPH
Director, Office of Infectious Diseases
Center for Drug Evaluation and Research
Office of New Drugs
U.S. Food and Drug Administration

Colin Shepard, MD
CDC Liaison to the Assistant Secretary for Preparedness and Response (ASPR)
Center for Preparedness and Response
Centers for Disease Control and Prevention

Rajesh Gandhi, MD
Director, HIV Clinical Services and Education, Massachusetts General Hospital
Professor of Medicine, Harvard Medical School

Adi V. Gundlapalli, MD, PhD
Co-Lead, Serology and Correlates of Protection Tiger Team, COVID-19 Response
Chief Public Health Informatics Officer
Center for Surveillance, Epidemiology, and Laboratory Services
Centers for Disease Control and Prevention


Title: Evaluating and Caring for Patients with Post-COVID Conditions

Date:
Thursday, June 17, 2021

Presenters:
Jennifer R. Chevinsky, MD, MPH
Epidemic Intelligence Service Officer
Post-COVID-19 Conditions Unit
COVID-19 Response
Centers for Disease Control and Prevention

Alex Vosooney, MD
Chair, Subcommittee on Clinical Recommendations and Policies
American Academy of Family Physicians

Michael Saag, MD
Professor of Medicine
Director, UAB Center for AIDS Research
University of Alabama Birmingham


Title: Underlying Medical Conditions and Severe COVID-19: Evidence-based Information for Healthcare Providers

Date:
Thursday, May 27, 2021

Presenters:
Kanta Sircar, PhD, MPH
Clinical Disease Team
COVID-19 Response
Centers for Disease Control and Prevention

John Brooks, MD, MPH
Chief Medical Officer
COVID-19 Response
Centers for Disease Control and Prevention

Sapna Bamrah Morris, MD, MBA
Clinical Disease Team Lead
Health Systems and Worker Safety Task Force
COVID-19 Response
Centers for Disease Contro​l and Prevention


Title: Lyme Disease Updates and New Educational Tools for Clinicians

Date:
Thursday, May 20, 2021

Presenters:
Grace Marx, MD, MPH
LCDR, U.S. Public Health Service
Medical Epidemiologist, Bacterial Diseases Branch
Division of Vector-Borne Diseases
Centers for Disease Control and Prevention


Title: What Clinicians Need to Know About Pfizer-BioNTech COVID-19 Vaccination of Adolescents

Date:
Friday, May 14, 2021

Presenters:
Sara Oliver, MD, MSPH
LCDR, U.S. Public Health Service
Co-lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
COVID-19 Response
Centers for Disease Control and Prevention

Kate Woodworth, MD, MPH
Medical Officer, Clinical Guidance Team
COVID-19 Response
Centers for Disease Control and Prevention

Tanya Myers, PhD, MSc
v-safe Team Co-Lead
COVID-19 Response
Centers for Disease Control and Prevention


Title: Johnson & Johnson/Janssen COVID-19 Vaccine and Thrombosis with Thrombocytopenia Syndrome (TTS): Update for Clinicians

Date:
Tuesday, April 27, 2021

Presenters:
Sara Oliver, MD
LCDR, U.S. Public Health Service
Co-lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
COVID-19 Response
Centers for Disease Control and Prevention

Tom Shimabukuro, MD, MPH, MBA
CAPT, U.S. Public Health Service
Vaccine Safety Team Lead
COVID-19 Response
Centers for Disease Control and Prevention


Title: Johnson & Johnson/Janssen COVID-19 Vaccine and Cerebral Venous Sinus Thrombosis with Thrombocytopenia – Update for Clinicians on Early Detection and Treatment

Date:
Thursday, April 15, 2021

Presenters:
Sara Oliver, MD
LCDR, U.S. Public Health Service
Co-lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
COVID-19 Response
Centers for Disease Control and Prevention

Tom Shimabukuro, MD, MPH, MBA
CAPT, U.S. Public Health Service
Vaccine Safety Team Lead
COVID-19 Response
Centers for Disease Control and Prevention


Title: The Role of Telehealth in Expanding Access to Healthcare During the COVID-19 Pandemic: Considerations for Vaccine Uptake and Monitoring for Adverse Events

Date:
Thursday, March 11, 2021

Presenters:
Erica Tindall, MSN, MPH, APRN, AGNP-C, CIC
Public Health Analyst, Senior Health Research Analyst
Peraton

Ann Mond Johnson
CEO
American Telemedicine Association

Michelle Rizor, MHSA
Principal, Strategic Partnerships – Virtual Health
Spectrum Health

Daniel Smith, PA-C
Lead Provider Informaticist
Spectrum Health

Todd Vento, MD, MPH, FACP, FIDSA
Medical Director, Infectious Diseases & Specialty TeleHealth
Intermountain Healthcare


Title: What Every Clinician Should Know about COVID-19 Vaccine Safety and Effectiveness and How to Address Patient Questions and Concerns

Date:
Tuesday, March 09, 2021

Presenters:
Tom Shimabukuro, MD, MPH, MBA
Vaccine Safety Team Lead
COVID-19 Response
Centers for Disease Control and Prevention

Kathleen Dooling, MD, MPH
Medical Officer
Co-lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
COVID-19 Response
Centers for Disease Control and Prevention

Stephen Perez, RN, PhD
LT, U.S Public Health Service
Clinical Lead, Vaccine Confidence Team
COVID-19 Response
Centers for Disease Control and Prevention


Title: What Clinicians Need to Know About Johnson & Johnson’s Janssen COVID-19 Vaccine

Date:
Tuesday, March 02, 2021

Presenters:
Sarah Mbaeyi, MD, MPH
CDR, U.S. Public Health Service
Medical Officer
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention

Sara Oliver, MD
LCDR, U.S. Public Health Service
Co-lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
COVID-19 Response
Centers for Disease Control and Prevention

Kathleen Dooling, MD, MPH
Medical Officer
Co-lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
COVID-19 Response
Centers for Disease Control and Prevention


Title: Treating Long COVID: Clinician Experience with Post-Acute COVID-19 Care

Date:
Thursday, January 28, 2021

Presenters:
Alfonso C Hernandez-Romieu, MD, MPH
LCDR, U.S. Public Health Service
Late Sequelae Unit, Clinical Team
COVID-19 Response
Centers for Disease Control and Prevention

Jennifer Possick, MD
Associate Professor, Section of Pulmonary, Critical Care and Sleep Medicine
Department of Internal Medicine
Yale University School of Medicine

Allison Navis, MD
Assistant Professor, Division Neuro-Infectious Diseases
Icahn School of Medicine at Mount Sinai
Mount Sinai Health System


Sign up for COCA Newsletters and Announcements

Sign up to receive COCA Call Announcements, COCA Newsletters and other COCA resources by entering your email address:

Page last reviewed: March 27, 2020